Acquiring Company
Lupin
Acquired Company
Renascience Pharma
LutonBiotechnologyHealth CareMedicalPharmaceuticalpharmaceuticalsBiotechnologyHealth CarePharmaceuticalDescription
Lupin has successfully acquired Renascience Pharma, a UK-based pharmaceutical company, for 12.3 million pounds. This acquisition aims to enhance Lupin's presence in the global pharmaceutical market and expand its product portfolio. The transaction reflects Lupin's strategy to invest in innovative markets to improve patient care. The acquisition marks a significant step in Lupin's growth strategy.
Who to call at Lupin, and when
When Lupin changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Lupin raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Lupin, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Lupin. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Lupin makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Renascience Pharma?
Renascience Pharma was acquired by Lupin. The deal was reported on April 3, 2025. Lupin is a Mumbai-based pharma major dedicated to advancing medical science and improving patient lives globally. Lupin is privately held and operates in Biotechnology.
When did Lupin acquire Renascience Pharma?
Lupin's acquisition of Renascience Pharma was reported on April 3, 2025. Lupin has successfully acquired Renascience Pharma, a UK-based pharmaceutical company, for 12.3 million pounds. This acquisition aims to enhance Lupin's presence in the global pharmaceutical market and expand its product portfolio. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Renascience Pharma do?
Renascience Pharma is a pharmaceutical company based in the United Kingdom. It focuses on the development and commercialization of innovative treatments. It is privately held, operating in Biotechnology, and is based in Luton.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.